Overuse of antibiotics as a key driver to antibiotic resistance in Morocco: A short review with potential solutions
Keywords:Antibiotic Resistance, Overuse of Antibiotics, Morocco
Antimicrobial resistance is a global public health challenge, which has accelerated by the overuse of antibiotics worldwide. Increased antimicrobial resistance is the cause of severe infections, complications, longer hospital stays and increased mortality. Steps must be taken to reverse the damage that has already been done and prevent further resistance from developing. This work will examine the context and societal situations that led to this acceptance of antibiotic overuse and misuse seen in both health care professionals and the public, the biochemical and genetic pathways that allow a microbe to develop drug resistance, the consequences that could follow if this trend of antibiotic overuse is allowed to continue and the various methods and solutions that have been suggested to prevent and reverse this problem.
World Health Organization (WHO). Antimicrobial resistance,
cited 4 Apr 2019. https://www.who.int/news-room/fact-sheets/
Moghnieh AR, Zeina A Kanafani A Z, Tabaja ZH, Sharara LS,
Awad SL, Kanj SS. Epidemiology of common resistant bacterial
pathogens in the countries of the Arab League. Lancet Infect Dis
; (12): e379-e394.
WHO. Global antimicrobial resistance surveillance system
(GLASS) report, 2018. http://www.who.int/glass/resources/
Michael CA, Dominey-Howes D, Labbate M. The antimicrobial
resistance crisis: causes, consequences,and management. Front
public Heal. Frontiers Media SA 2014; 2: 145
Ackerman S, Gonzales R. The context of antibiotic overuse. Ann
Intern Med 2012; 157(3):211-212
Arason VA, Sigurdsson AJ. The problems of antibiotic overuse.
Scand J Prim Health Care 2016; 28(2): 65-66.
Llor C, Lars Bjerrum L Antimicrobial resistance: Risk associated
with antibiotic overuse and initiatives to reduce the problem.
Ther Adv Drug Sa 2014; 5(6): 229-241.
Levy, Stuart B, 2002. The antibiotic paradox: How the misuse
of antibiotics destroys their curative Power. Cambridge, MA:
Perseus Publication, USA.
Hhm H, Ma M, Jin G, Jin Y, Khalifa I, Zeng Q, et al. Virulence
factors of staphylococcus aureus isolated from korean pork
bulgogi: Enterotoxin production and antimicrobial resistance.
Korean J Food Sci An 2015; 35(4): 502-506.
Lashley, R. Felissa and Jerry D. Durham,2002. Emerging
infectious diseases: Trends and issues. New York: Springer
Schmidt, Michael A, 2009. Beyond antibiotics: Strategies for
living in a world of emerging infections and antibiotic-resistant
bacteria. Berkeley, CA: North Atlantic Books,USA.
Shallcross, Laura J, and Dame Sally C Davies. (2014). Antibiotic
overuse: A key driver of antimicrobial resistance. Brit J Gen Pract
; 64(629): 604-605.
Huttner B, Harbarth S. Antibiotics are not automatic anymoreâ€™
the French national campaign to cut antibiotic overuse. PLoS
Medicine 2009; 6(6: e1000080.
Mainous AG 3rd, Hueston WJ, Love MM, Evans ME, Finger R.
(2000). An evaluation of statewide strategies to reduce antibiotic
coveruse. Fam Med 2000; 32(1): 22-915.
McKenna, John, 2014. Anti-Biotics: Are they curing us or killing
us? Dublin: Gill and McMillan, England
Shallcross LJ, Dame SC D. Antibiotic overuse: A key driver of
antimicrobial resistance. Br J Gen Pract; 2014; 64(629): 604-605.
Sahreena L, Kunyan Z. Methicillin-Resistant Staphylococcus
aureus: Molecular Characterization, Evolution, and
Epidemiology. Clin Microbiol Rev 2018; 31 (4).
Foster TJ. Antibiotic resistance in Staphylococcus aureus.
Current status and future prospects. FEMS Microbiol Rev. 2017;
Holger S, BreitrÃ¼ck A. Clostridium difficile - From Colonization
to Infection. Front. Microbiol 2018; https://doi.org/10.3389/
Zerouali K, Ramdani-Bouguessa N, Boye C, Hammami A& The
Active 2 Group. Multicentric study in five African countries of
antibiotic susceptibility for three main pathogens: Streptococcus
pneumoniae, Staphylococcus aureus, and Pseudomonas
aeruginosa, J Chemother 2016; 28: 266-272.
Zorgani A, Almagatef A, Sufya N, Bashein A, Tubbal A. Detection
of CTX-M-15 Among Uropathogenic Escherichia coli Isolated
from Five Major Hospitals in Tripoli, Libya. Oman Med J. 2017;
Mathlouthi N, Al-Bayssari C, El Salabi A, Bakour S, Ben Gwierif
S, Zorgani AA, Jridi Y, Ben Slama K, Rolain JM, Chouchani
C. Carbapenemases and extended-spectrum Î²-lactamases
producing Enterobacteriaceae isolated from Tunisian and Libyan
hospitals. J Infect Dev Ctries. 2016; 2; 10(7):718-27.
Yahiaoui M, Robin F, Bakour R, Hamidi M, Bonnet R, Messai
Y. Antibiotic resistance, virulence, and genetic background
of community-acquired uropathogenic Escherichia coli from
Algeria. Microb Drug Resist 2015; 21: 516-26.
Abujnah A, Zorgani A, Sabri M, El-Mohammady H, Khalek R,
Ghenghesh K. Multidrug resistance and extended-spectrum
Î²-lactamases genes among Escherichia coli from patients with
urinary tract infections in northwestern Libya. Libyan J Med
; 10: 26412.
Mansour W, Grami R, Ben Haj Khalifa A, et al. Dissemination of
multidrug-resistant blaCTX-M-15/IncFIIk plasmids in Klebsiella
pneumoniae isolates from hospital- and community-acquired
human infections in Tunisia. Diagn Microbiol Infect Dis 2015;
Alem N, Frikh M, Srifi A, et al. Evaluation of antimicrobial
susceptibility of Escherichia coli strains isolated in Rabat
University Hospital (Morocco). BMC Res Notes 2015; 8: 392.
Arhoune B, Oumokhtar B, Hmami F, et al. Rectal carriage
of extended-spectrum Î²-lactamase- and carbapenemaseproducing
Enterobacteriaceae among hospitalised neonates in a
neonatal intensive care unit in Fez, Morocco. J Glob Antimicrob
Resist 2017; 8: 90-96.
Barguigua A, El Otmani F, Talmi M, et al. Prevalence and
genotypic analysis of plasmid-mediated Î²-lactamases among
urinary Klebsiella pneumoniae isolates in Moroccan community.
J Antibiot 2013; 66: 11-16.
Hanane El Hafa, Kawtar Nayme, Najia El Hamzaoui, Itto
Maroui, Mohammed Sbiti, Khalid Zerouali K. Dissemination of
carbapenem-resistant Acinetobacter baumannii strains carrying
the blaGES, blaNDM and blaOXA23 in Morocco. Germs. 2019;
Natoubi S, Barguigua A, Zerhouni N, et al. First report of an
OXA-58 carbapenemase producing Acinetobacter baumannii
isolated from urinary tract infection in Morocco. Afr J Urol.
Bonomo AR, Burd ME, Conly J, Limbago MB, Poirel L, Segre AJ,
et al. Carbapenemase-Producing Organisms: A Global Scourge
Clin Infect Dis. 2018; 66(8): 1290-1297.
Elias C, Moja L, Mertz D, et al. Guideline recommendations and
antimicrobial resistance: the need for a change. BMJ Open 2017;
Battin, M. Pabst. (2009). The patient as victim and vector: Ethics
and infectious disease. New York: Oxford UP,USA.
CDC. Antibiotic Use in the United States, 2017: Progress and
Opportunities. Atlanta, GA: US Department of Health and
Human Services, CDC.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles are published Under License of Creative Commons Attribution 3.0 License Â©
Copyright policies & self-archiving
|Author's Pre-print:||author can archive pre-print (ie pre-refereeing)|
|Author's Post-print:||author can archive post-print (ie final draft post-refereeing)|
|Publisher's Version/PDF:||author can archive publisher's version/PDF|